Form 8.3 - Dechra Pharmaceuticals plc

By Regulatory News

Regulatory News | 15 Jan, 2024

Updated : 13:58

RNS Number : 7364Z

Barclays PLC

15 January 2024

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				DECHRA PHARMACEUTICALS PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				12 Jan 2024
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				1p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			6,702,714	5.88%	552,736	0.49%
(2)	Cash-settled derivatives:
	and/or controlled:			549,639	0.48%	6,630,646	5.82%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			7,252,353	6.37%	7,183,382	6.31%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
1p ordinary		Purchase		265,492		38.6439 GBP
1p ordinary		Purchase		60,173		38.6400 GBP
1p ordinary		Purchase		43,037		38.6434 GBP
1p ordinary		Purchase		31,128		38.6593 GBP
1p ordinary		Purchase		7,484		38.6500 GBP
1p ordinary		Purchase		6,736		38.6429 GBP
1p ordinary		Purchase		6,196		38.6534 GBP
1p ordinary		Purchase		4,974		38.6592 GBP
1p ordinary		Purchase		3,254		38.6600 GBP
1p ordinary		Purchase		91		38.6418 GBP
1p ordinary		Sale		379,534		38.6406 GBP
1p ordinary		Sale		91,558		38.6484 GBP
1p ordinary		Sale		63,223		38.6400 GBP
1p ordinary		Sale		13,277		38.6443 GBP
1p ordinary		Sale		4,736		38.6419 GBP
1p ordinary		Sale		4,128		38.6500 GBP
1p ordinary		Sale		1,293		38.6200 GBP
1p ordinary		Sale		977		38.6600 GBP
1p ordinary		Sale		7		38.6357 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
1p ordinary		SWAP		Closing Long		1,668	38.6472 GBP
1p ordinary		SWAP		Decreasing Short		7	38.6361 GBP
1p ordinary		SWAP		Decreasing Short		529	38.6561 GBP
1p ordinary		SWAP		Decreasing Short		1,042	38.6442 GBP
1p ordinary		SWAP		Decreasing Short		2,179	38.6400 GBP
1p ordinary		SWAP		Decreasing Short		8,731	38.6370 GBP
1p ordinary		SWAP		Decreasing Short		379,534	38.6406 GBP
1p ordinary		SWAP		Increasing Short		91	38.6418 GBP
1p ordinary		SWAP		Increasing Short		2,468	38.6496 GBP
1p ordinary		SWAP		Increasing Short		3,910	38.6507 GBP
1p ordinary		CFD		Increasing Short		5,575	38.6593 GBP
1p ordinary		SWAP		Increasing Short		8,544	38.6510 GBP
1p ordinary		SWAP		Increasing Short		13,147	38.6400 GBP
1p ordinary		SWAP		Increasing Short		25,553	38.6593 GBP
1p ordinary		SWAP		Increasing Short		263,024	38.6438 GBP
1p ordinary		SWAP		Opening Short		15,488	38.6400 GBP
1p ordinary		SWAP		Opening Short		16,144	38.6545 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				15 Jan 2024
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEADFSFSLLEFA

Form 8.3 - Dechra Pharmaceuticals plc

Last news